Viral infections and pandemics have been exerting a significant economic cost burden on health care systems around the world. Despite development of new treatment paradigms for viral infections, infections such as the human immunodeficiency virus (HIV) and hepatitis have been responsible for numerous deaths globally. Health care providers are constantly engaged in the development of accurate and rapid diagnostic test kits for viral infections. There has been a gradual shift toward new techniques and methods of diagnosis of viral infections, including nucleic acid amplification test (NAAT), which have shown promising results with improved accuracy and reduced time of diagnosis. Clinical management of viral infections and efficient screening are two major pillars of viral infection management. There is an improved focus on efficient screening and diagnosis of viral infections for prevention of diseases and timely treatment. This has led to the development of new and advanced viral diagnostic test kits.
Request a PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=46338
Rise in incidence of viral infections such as hepatitis, respiratory syncytial virus, and human immunodeficiency virus (HIV) worldwide is expected to boost the viral diagnostic test kits market. Moreover, outbreak of new viral infections in the recent past such as Ebola, hemorrhagic fever, and swine influenza a virus is driving demand for new and innovative virus diagnostic test kits across the world. According to the World Health Organization (WHO), in 2013, an estimated 35 million people were suffering from HIV, while an estimated 350 to 400 million people were carriers of the chronic hepatitis B virus in 2014. Furthermore, hepatitis B and hepatitis C viral infections are responsible for approximately 780,000 deaths and 500,000 deaths, respectively, each year globally. This is leading to a rise in demand for virus diagnostic test kits. Additionally, new techniques and recent developments in the methods applied for virus testing have led to the introduction of new rapid diagnostic test kits. This is projected to further fuel the expansion of the global virus diagnostic test kits market from 2018 to 2026. However, high price of new test kits is a major restraining factor for the adoption of these kits in emerging countries, which are currently relying on traditional and time consuming test kits for virus detection.
The global virus diagnostic test kits market can be segmented based on type, test, end- user, and region. Based on type, the global virus diagnostic test kits market can be classified into influenza test kits, hepatitis test kits, human immunodeficiency virus test kits, respiratory syncytial virus test kits, and others. In terms of test, the global virus diagnostic test kits market can be categorized into traditional tests (cell culture test, complement fixation test (CFT), Haemagglutination inhibition test, and others) and rapid tests (nucleic acid amplification test (NAAT), immunoassay test, next generation sequencing (NGS), and mass spectrometry). Based on end-user, the global virus diagnostic test kits market can be segmented into diagnostic & clinical laboratories, academic & research institutes, contract research organizations, and others.
Request for Analysis of COVID19 Impact on Viral Diagnostic Test Kits Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=46338
In terms of region, the global virus diagnostic test kits market can be categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2017. Introduction of new and rapid test kits, regulatory approvals for these kits, and rise in prevalence of viral infections among the general population are some of the major factors driving the virus diagnostic test kits market in North America in 2018. The market in Middle East & Africa is projected to expand at a comparatively higher CAGR from 2018 to2026, owing to a large patient pool suffering from viral infections, including HIV and other pandemic infections.
Key players operating in the global virus diagnostic test kits market are Abbott, Autobio, Certest Biotec S.L., CorisBioconcept SPRL, F. Hoffman La Roche, Ltd., VIDIA s.r.o, Hologic Inc., bioMérieux SA, and Quidel Corporation.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
Buy now Viral Diagnostic Test Kits Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=46338<ype=S
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
More Trending Reports by Transparency Market Research:
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.”
Contact
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Transparency Market Research (TMR) has published a new report titled, ‘Multiplexed Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.
According to the report, the global multiplexed diagnostics market was valued at around US$ 8.7 Bn in 2018 and is projected to grow at a CAGR of 17.9% from 2019 to 2027.OverviewDiagnostic assays are tests used to assess target analytes, quantitatively or qualitatively, in biochemical substances, cells of an organism, or an organic sample for disease diagnosisMultiplexed diagnostics screen multiple analytes in a single cycle of assay procedure.
Though single plex assays are widely available in the market, they fail to yield results for multiple analytes in a single cycle of assay process, and thus when multiple analytes are needed to be screened, cost and turnaround time of single plex assay is higher as compared to multiplexed assay.Rising demand for advanced diagnostic technology for accurate diagnosis of life-threatening diseases is the major factor to drive the global market.North America dominated the global multiplexed diagnostics market in 2018 and anticipated to dominate during the forecast period.Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=1719Significant private and public funding for genomics and personalized medicine to Drive MarketGrowing demand for automated equipment and multifaceted analytical strategies is the major driver for the growth of global multiplexed diagnostics market.Rising demand for advanced diagnostic technology for accurate diagnosis of life-threatening diseases and Increasing prevalence of cancer and infectious diseases are some of the major factors responsible for the growth of global multiplexed diagnostics marketFor instance, as per WHO 2010 data, Breast cancer is one of the most common causes of mortality among females, accounting for 25% of total cancer cases and 15% of cancer mortality across the world (WHO, 2010).Moreover significant private and public funding for genomics and personalized medicine is also fuelling the growth of global multiplexed diagnostics market.Medium Density Multiplexed Assays Segment to Dominate MarketBased on technology, the global multiplexed diagnostics market has been segmented into Very High Density Multiplexed Assays, High Density Multiplexed Assays, Medium Density Multiplexed Assays, Low Density Multiplexed Assays, and Next Generation SequencingMedium Density Multiplexed Assays segment is accounted for major market share in 2018 and is expected to dominate throughout the forecast period owing to increasing use in genetic research.Increasing emerging diseases that need new diagnosis tests and new drug development create demand for high density multiplexed assaysRequest for Analysis of COVID-19 Impact on Multiplexed Diagnostics Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=1719Cardiac Diseases- More Lucrative Application SegmentBased on application, the global multiplexed diagnostics market has been divided into Infectious Disease Diagnostic, oncology, autoimmune diseases, cardiac diseases, allergies, and othersOncology segment dominated the global market in 2018 due to Product developments that enable smooth, fast procedure for both the physician and patient, and increase in incidence of diseases associated with breast cancer, colorectal cancer, and prostate cancerCardiac diseases segment is more promising segment during the forecast period owing to rising prevalence of cardiac diseases and development of important biomarkers for cardiac disease detectionAcademic research institutes Segment- Lion Market ShareBased on end-user, the global multiplexed diagnostics market has been segmented into academic research institutes, hospitals, diagnostic laboratories, pharmaceutical companies, and clinical research organizationsAcademic research institutes is accounted for major market share in 2018.
Increasing research projects in the field of genetic engineering is the key factor driving the segment.Buy Multiplexed Diagnostics Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=1719=SNorth America to Dominate Global MarketIn terms of region, the global multiplexed diagnostics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.North America accounted for major share of the global multiplexed diagnostics market in 2018.
Increasing use of multiplexed diagnostics in academic and research institutes, large number of people with oncology and infectious diseases, several market players in the U.S., technological advancements, extensive R practices, and increasing awareness about the diagnosis and treatment are likely to boost market growth in the U.S.For instance, the University of California San Francisco (UCSF) has seven PCR installations for its academic researchThe multiplexed diagnostics market in Asia Pacific is anticipated to expand at a high CAGR from 2019 to 2027.
This can be ascribed to growing aging population, high incidence of various diseases, and increased research activities in the region.Competitive LandscapeThe global multiplexed diagnostics market is consolidated as few players hold major market share in global market.Key players include Agilent Technologies, bioMérieux SA, Bio-Rad Laboratories, Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd., Hologic, Inc., Luminex Corporation, Siemens Healthineers, Thermo Fisher Scientific, Inc., Abbott Laboratories, among othersMore Trending Reports by Transparency Market Research –Dental Consumables Market: https://www.prnewswire.com/news-releases/as-dental-problems-spike-due-to-increasing-geriatric-population-dental-consumables-market-prepares-to-witness-growth-tmr-301078561.htmlRead our Case study at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-upAbout UsTransparency Market Research is a global market intelligence company providing global business information reports and services.
Veterinary Molecular Diagnostics Market: IntroductionAccording to the report, the global veterinary molecular diagnostics market was valued at US$ 479.3 Mn in 2019 and is projected to expand at a CAGR of ~8% from 2020 to 2030.
Different technologies are used in the diagnosis of veterinary diseases, including conventional PCR, singleplex PCR, multiplex PCR, and real-time PCR.
The market in the region is projected to expand at a high CAGR from 2020 to 2030.Increase in Zoonotic Disease Concerns and Rise in Pet Ownership & Spending in Pet Industry to Drive Global MarketA disease that spreads between animals and humans is termed as zoonotic disease.
It can be caused by viruses, bacteria, parasites, and fungi.
A second wave of automation, which includes replacement of existing old technology and low throughput automated systems with advanced fully automated and high throughput systems, is anticipated to lead to uptake of automated veterinary molecular diagnostic analyzer units in the market.Moreover, consolidation among diagnostic laboratories and rise in demand for small volume point-of-care automated veterinary molecular diagnostic analyzer systems are projected to fuel the growth of the segment.
The growth of the segment can be attributed to advantages of automated instruments & software such as quick results with less labor.Request Customization on Veterinary Molecular Diagnostics Market Report –https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=42437Real-time PCR to be Highly Lucrative TechnologyBased on technology, the global veterinary molecular diagnostics market has been categorized into conventional PCR, singleplex PCR, multiplex PCR, real-time PCR, and others.
The global cancer biomarker market will reach a valuation of US$ 27 Bn by the end of 2025, as projected by a new Fact.MR report.
The growth is primarily driven by the increasing prevalence of cancer and the subsequent investments in research and development activities.
Factors further complementing the growth are favorable government funding initiatives on cancer diagnostics.Cancer Biomarker Market: Key FindingsCirculating Tumor Test (CTT) and Prostate Specific Antigen (PSA) test collectively account for more than half of overall market value.On the back of high cigarette smoking, lung cancer is expected to be the most common type of cancer, thereby accounting for a quarter total market share in testing.North America is set to account for a large portion of the overall global revenue, on the back of heavy budget allocation by the government for cancer research and training.Asia-Pacific will witness tremendous growth owing to the increasing affordability of cancer treatments in emerging economies.Request for Sample detailed COVID-19 impact analysis on the Market @ https://www.factmr.com/connectus/sample?flag=S_id=4587Cancer Biomarker Market: Key Driving FactorsGovernments in developed and emerging economies are financing clinical trials, thus enabling companies to develop effective diagnostics and treatments for cancer diseases, thus giving a significant boost to the global cancer biomarker market.Invigorated by technological advancements, numerous companies in the diagnostic imaging market are developing advanced, efficient, and economical equipment, and hence, are gaining traction among end-users.Cancer Biomarker Market: Key RestraintMajor factors possessing a challenge to the rapid growth of the market are reluctance among end-users to adopt new technologies and the high cost of biomarker techniques.Competition LandscapeSome of the key players in the global cancer biomarker market are F. Hoffmann-La Roche Ltd., Abbott Technologies & Merck & Co., Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Illumina, Inc., bioMérieux SA, Hologic, Inc., Genomic Health, Inc., and QIAGEN, among others.
The market players are adopting Artificial Intelligence (to) to develop their offerings and to decode the cancer pathology.For More Detailed Information about Methodology @ https://www.factmr.com/connectus/sample?flag=RM_id=4587About the ReportThis 170-page study offers a detailed market forecast on the cancer biomarker market.
The key categories covered in the report include Market statistics have been presented on the basis of Test Type (PSA tests, CTC tests, AFP tests, CA tests, HER2 tests, BRCA tests, ALK tests, CEA tests, EFGR mutation tests, KRAS mutation tests, and Others) and Disease Indication (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, etc.)
across five major regions.Press Release: https://www.factmr.com/media-release/1360/global-cancer-biomarkers-market
The global Sepsis Treatment Market study presents a careful compilation of the historical, current, and future outlook of the said market as well as the factors that are responsible for such development of the market.
In an effort to provide the users of this report with a comprehensive view of the global Sepsis Diagnostics market, experts have made an inclusion of a detailed discussion on and analysis of the diverse product portfolio and competitive vendor landscape of each of the leading players spread across different territories of the world.
The report also adds an analysis of market attractiveness, in which all of the market segments have been benchmarked based on general attractiveness, their rate of growth, and size of the market.Analysts at Fact.MR have highlighted the opportunities, threats, weaknesses, and strengths of each of the players in the global Sepsis Diagnostics market.
In addition to that, the study makes an emphasis on the pattern of adoption of Sepsis Diagnostics product / services across various industries.
According to a study by Fact.MR, the global sepsis diagnostics market is expected to witness strong growth, registering 7.7% CAGR during the forecast period 2017-2026.
The global sepsis diagnostics market is also projected to generate US$ 707.3 million revenue by the end of 2026.Request to View Sample of Research Report @ https://www.factmr.com/connectus/sample?flag=S_id=391The Sepsis Diagnostics market report highlights and analyses the following players:Biomérieux SAThermo Fisher Scientific IncAbbott Laboratories, IncLuminex CorporationThe Sepsis Diagnostics market report conducts examination of the operating pattern of each of the market players – acquisitions, launch of new product launches, collaborations, and partnerships – has been investigated into detail.The ongoing global pandemic, COVID-19, has affected the global Sepsis Diagnostics market adversely.
Barium, a chemically inert and dense mineral, is used in a number of end-use industries.
It is also quite interesting to note that not only are certain areas identified as hotbeds of exploration, they are also highly productive.” Some of these are the Mediterranean region, Africa, and Latin America.In terms of BOE (Barrels of Oil Equivalent), the new regions show a performance of 26 discoveries - 100 BOE, out of the 12.2 billion barrels BOE discovered in 2019.
This shows how conventional discoveries are moving on a high trajectory.The study report on the global barite market, prepared by Transparency Market Research states that the market would chart a decent CAGR (Compound Annual Growth Rate) of 4.8 percent – in the period 2018-2026 Request Sample pages of premium Research Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=2404Consolidated Vendor Landscape to Mark Global Barite Market over the Forecast PeriodThe competitive landscape of the global barite market is consolidated and the trend will continue over the forecast period.
Apart from improving the product quality, players are looking to work with different grades in order to widen the scope of applications.Some of the players that are seen as high performers in the global barite market include Spectrum Chemical Manufacturing Corporation, Deutsche Baryt Industrie, Halliburton, CIMBAR Performance Minerals, New Riverside Ochre Company, Inc., Excalibar Minerals LLC, and Anglo Pacific Minerals, among others.It is pertinent to note here that the top tier players that are operating in the global barite market landscape have a hold on about 55% of the total market share.
It is also important to note that these players are scurrying to improve plant facilities for bettering capacity in terms of production.North America to Show Stellar Performance over the Forecast PeriodDominating the regional landscape of the global barite market, North America will ride to growth on the back of strong presence of key market players and numerous end-use industries in its landscape.
However, market expert’s note, “Oil and gas segment in the region will lose to rubber and plastics over the period to come.”Request for covid19 Impact Analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19_id=2404About UsTransparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.Our reports are single-point solutions for businesses to grow, evolve, and mature.
The global electrical appliances market was valued at around US$ 685 Bn in 2016 and is anticipated to register a CAGR of ~7% from 2017 to 2025, according to a new report by Transparency Market Research (TMR) titled “Electrical Appliances Market- Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025.”Electrical appliances are defined as devices which use electricity to perform specific functions.
A wide range of such appliances is available from refrigerators, wine-coolers, washing machines, tumble dryers, vacuum cleaners, steam mops, shavers, trimmers and water heaters to air conditioners, air coolers, heaters, fans, rice cookers, bread makers, toasters, irons, and juicers.
Interpret a Competitive outlook Analysis Report with PDF Brochure - https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=41387Higher standards of living and availability of lucrative product offers and purchase credit schemes to drive the market for electrical appliancesOne of the primary drivers of the market is higher standards of living, especially in the Asia Pacific region.
The major restraint on the global electrical appliances market is the consistent and considerable R investment required to develop new, more efficient, environment-friendly, smart, and connected appliances.
It is a highly competitive market coupled with increasingly stringent government regulations regarding emissions of environmentally harmful chemicals.
In such a scenario, the constant improvement of products is important, though this is mostly possible only by the larger companies such as Whirlpool Corporation, Haier Group, and LG Electronics Inc.Product differentiation and new product development are expected to be among the available opportunities in the global electrical appliance market during the forecast periodMajor opportunities in the global electrical appliances market exist in product differentiation and new product development.
